C WorldWide Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-38,168
| Closed | -$2.65M | – | 104 |
|
|
2019
Q1 | $2.65M | Buy |
38,168
+16,403
| +75% | +$1.14M | 0.03% | 81 |
|
|
2018
Q4 | $946K | Sell |
21,765
-22,585
| -51% | -$982K | 0.01% | 101 |
|
|
2018
Q3 | $3.39M | Sell |
44,350
-8,484
| -16% | -$648K | 0.04% | 79 |
|
|
2018
Q2 | $4.06M | Sell |
52,834
-9,143
| -15% | -$703K | 0.06% | 74 |
|
|
2018
Q1 | $3.16M | Sell |
61,977
-9,463
| -13% | -$482K | 0.05% | 66 |
|
|
2017
Q4 | $3.31M | Sell |
71,440
-6,251
| -8% | -$290K | 0.05% | 69 |
|
|
2017
Q3 | $4.14M | Buy |
77,691
+764
| +1% | +$40.7K | 0.06% | 71 |
|
|
2017
Q2 | $4.78M | Buy |
76,927
+18,257
| +31% | +$1.13M | 0.07% | 62 |
|
|
2017
Q1 | $3.98M | Buy |
58,670
+4,445
| +8% | +$301K | 0.07% | 63 |
|
|
2016
Q4 | $3.81M | Sell |
54,225
-21,275
| -28% | -$1.5M | 0.07% | 61 |
|
|
2016
Q3 | $5.36M | Buy |
75,500
+14,500
| +24% | +$1.03M | 0.09% | 50 |
|
|
2016
Q2 | $2.98M | Buy |
61,000
+21,000
| +53% | +$1.03M | 0.06% | 62 |
|
|
2016
Q1 | $2.53M | Hold |
40,000
| – | – | 0.05% | 62 |
|
|
2015
Q4 | $4.49M | Hold |
40,000
| – | – | 0.08% | 56 |
|
|
2015
Q3 | $3.85M | Buy |
+40,000
| New | +$3.85M | 0.06% | 62 |
|